#FRAILAF - Twitter Hashtag

over 2 years ago

Rethinking cholinesterase Inhibitors, icosapent ethyl, fenofibrate and some controversial OAC data in the frail! Read all about it 👉 https://t.co/VACQoXu6tN #EHJPharmacotherapy #MACE #repurposingofdrugs #fibrates #frailAF #DOAC

0

11

6

2

3K

SABOURETCardiologist @SABOURETCardio

about 3 years ago

Effectiveness and Safety of Anticoagulation Therapy in Frail Patients with #AF. Despite #FRAILAF at #ESCCongress I won’t change my practice. The right #DOAC at the right #Dose https://t.co/MTGnvgLEGR

2

29

7

1

3K

Daniel Munhoz @DMunhoz

about 3 years ago

#FRAILAF Can #CardioTwitter (Is it #CardioX now?) explain to me how come there was more bleeding in the NOAC group? 🩸 NOAC is easier to use and safer. 🎯 VKA is difficult to keep on target. 🧍‍♂️Are these day to day patients? 📊Can I use these results in Brazil? #AtrialFibrilation

DMunhoz's tweet photo. #FRAILAF
Can #CardioTwitter (Is it #CardioX now?) explain to me how come there was more bleeding in the NOAC group?

🩸 NOAC is easier to use and safer.
🎯 VKA is difficult to keep on target.
🧍‍♂️Are these day to day patients?
📊Can I use these results in Brazil?
#AtrialFibrilation https://t.co/9HeSx4Z4M7

1

2

1

475

Rhys Williams @RhysWMPharm

about 3 years ago · Coychurch

@BirkhoelzerS Great piece of research. I do think that INR monitoring can be cruel for elderly, frail patients. Will be interesting to see how services adapt with this new evidence! #FRAILAF

2

9

1

0

1K

Lukas Weberling @weberlingld

about 3 years ago

Wow that was surprising. Switch from VKA to NOAC in frail patients leads to more (!) bleeding in the #frailAF trial at the #ESCCongress2023 hot line session. Designed as superiority trial, turned out otherwise